Zilbrysq is available through the specialty pharmacy PANTHERx Rare Pharmacy and through a Risk Evaluation and Mitigation Strategy (REMS) program because of the risk of serious meningococcal infections.
This year, UBC has partnered with Seqster and acquired Marketshare Movers to advance the company’s capabilities in clinical trials and co-pay and affordability programs
FINTEPLA will be launched through a restricted distribution program, called the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) Program, and is expected to be available through Zogenix’s specialty pharmacy partner Anovo
McKesson Specialty Health launched its enhanced Third Party Logistics (3PL) services, which now offer even more robust, comprehensive support to pharmaceutical, biologic and medical surgical manufacturers. Customized to each customer’s needs and products, these order-to-cash and billback 3PL services encompass every step of supply chain management so patients can get the critical therapies they need. […]